| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advanced drug delivery 2020 and beyond: Perspectives on the future
|
Bae, You Han
|
|
|
158 |
C |
p. 4-16
|
artikel
|
| 2 |
Controlling timing and location in vaccines
|
Irvine, Darrell J.
|
|
|
158 |
C |
p. 91-115
|
artikel
|
| 3 |
CRISPR/Cas systems to overcome challenges in developing the next generation of T cells for cancer therapy
|
Huang, Dennis
|
|
|
158 |
C |
p. 17-35
|
artikel
|
| 4 |
Dancing with reactive oxygen species generation and elimination in nanotheranostics for disease treatment
|
Zhou, Zijian
|
|
|
158 |
C |
p. 73-90
|
artikel
|
| 5 |
Editorial board members
|
|
|
|
158 |
C |
p. ii
|
artikel
|
| 6 |
Engineered tissues and strategies to overcome challenges in drug development
|
Khalil, Andrew S.
|
|
|
158 |
C |
p. 116-139
|
artikel
|
| 7 |
Exploiting nanoscale cooperativity for precision medicine
|
Wilhelm, Jonathan
|
|
|
158 |
C |
p. 63-72
|
artikel
|
| 8 |
Physical triggering strategies for drug delivery
|
Sun, Tao
|
|
|
158 |
C |
p. 36-62
|
artikel
|
| 9 |
Publisher’s note
|
|
|
|
158 |
C |
p. 1
|
artikel
|
| 10 |
Three significant highlights of controlled drug delivery over the past 55Â years: PEGylation, ADCs, and EPR
|
Hoffman, Allan S.
|
|
|
158 |
C |
p. 2-3
|
artikel
|
| 11 |
Translational considerations in nanomedicine: The oncology perspective
|
Gabizon, Alberto A.
|
|
|
158 |
C |
p. 140-157
|
artikel
|
Tijdschrift beschrijving